本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tarsus Pharmaceuticals, Inc.

68.96
+1.442.13%
成交量:45.61万
成交额:3,140.87万
市值:29.11亿
市盈率:-29.82
高:70.07
开:67.60
低:67.00
收:67.52
52周最高:76.81
52周最低:38.51
股本:4,221.41万
流通股本:3,035.16万
量比:1.10
换手率:1.50%
股息:- -
股息率:- -
每股收益(TTM):-2.3129
每股收益(LYR):-3.0729
净资产收益率:-31.46%
总资产收益率:-14.06%
市净率:8.75
市盈率(LYR):-22.44

数据加载中...

2025/09/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities